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In spite of effort to reduce human exposure,
lead toxicity continues to be a major environ-
mental health concern in the United States
and in other industrial countries. Although
recent research has focused on understanding
its toxic effects in the developing peripheral
and central nervous system, Pb also impacts
other developmental processes, including those
that occur in the hematologic and skeletal sys-
tems (Hicks et al. 1996; Landrigan 1991;
Nemoto et al. 2000; Waldron 1979). In fact,
the skeleton has long been recognized as a
major reservoir for ingested Pb (Barry 1975),
and a number of reports demonstrate an
inverse correlation between blood Pb concen-
trations and growth in terms of height, weight,
and chest circumference (Schwartz et al. 1986;
Shukla et al. 1989, 1991).
Given the strong epidemiologic data, as
well as our ﬁndings that fracture healing and
chondrocyte differentiation are affected by Pb,
we have performed a series of in vitro experi-
ments to elucidate the underlying mechanism
of toxicity during chondrogenesis and chondro-
cyte differentiation. We employed micromass
cultures of mesenchymal stem cells, a culturing
technique that has been used previously as a
model to study the early events of embryonic
limb development (Ahrens et al. 1993). Cell
lines with chondrogenic potential, such as
C3H10T1/2 cells, and primary limb bud mes-
enchymal cells plated at high density undergo
differentiation to form distinct cartilage nod-
ules. Thus, besides being used to study limb
development, these models have been used to
deﬁne factors and signaling events involved in
chondrogenesis (Weston et al. 2000; Weston
and Underhill 2000). Transforming growth
factor-β (TGF-β) and bone morphogenetic
protein (BMP) both induce chondrogenesis in
mesenchymal stem cell populations (Chen et al.
1991; Frenz et al. 1994; Iwasaki et al. 1993;
Joyce et al. 1990). Prostaglandin E2, through
protein kinase A signaling also induces chon-
drogenesis (Biddulph et al. 1988b; Capehart
et al. 1990; Clark et al. 2005), whereas retinoic
acid is considered an inhibitor of chondrogenic
commitment (Biddulph et al. 1988a; Jiang
et al. 1995) possibly via down-regulation of
TGF-β/Smad signaling (Yu and Xing 2006).
Thus various signaling pathways are associated
with chondrogenesis, but BMP signaling is par-
ticularly important because recombinant BMP
proteins are currently approved for clinical use
to enhance bone healing in tibia nonunions
and spine fusion.
Regarding the signaling pathways, TGF-β
and BMP signals are mediated by Smad 
transcription factors that bind to type I TGF-β
receptors and are phosphorylated following lig-
and binding to type II receptors (Massague
et al. 1997; Mehra and Wrana 2002). Both the
BMP receptor–associated Smads (1, 5, and 8)
and the TGF-β receptor–associated Smads (2
and 3) are released into the cytoplasm upon
phosphorylation, complex with Smad4, and
translocate into the nucleus where they regu-
late gene expression. Because TGF-β receptor–
and BMP receptor–associated Smads compete
for Smad4 and other downstream signaling
molecules, these pathways antagonize one
another such that when one pathway increases,
the other decreases (Candia et al. 1997). They
also have opposing effects in chondrocytes in
which TGF-β inhibits (Ballock et al. 1993;
Zhang et al. 2004) and BMP promotes
(Grimsrud et al. 1999, 2001; Leboy et al.
1997) chondrocyte differentiation. However,
in mesenchymal stem cells, both TGF-β and
BMP have been shown to enhance chondro-
genesis, with the most robust effect in response
to BMP signaling (Tuan 2003; Zhang et al.
2004). Assessing the impact of Pb on the pro-
pogation of these specific signaling events
would provide mechanistic insight into how
Pb may affect chondrogenesis and chondrocyte
differentiation.
Regarding possible molecular mechanisms
of toxicity, Pb has been shown to regulate
and alter numerous signaling pathways. Pb
has been shown block calcium signaling,
inhibit Ca2+/phospholipid-dependent protein
kinase C (PKC) signaling in neurologic tissues,
and interfere with long-term learning and
other functions (Pokorski et al. 1999; Vazquez
and Pena 2004). Calcium-independent effects
include neuronal release of γ-aminobutyric
acid (Braga et al. 1999), induction of ERK1/2
(extracellular signal regulated kinase 1 and 2)
and p38 (mitogen-activated protein kinase;
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BACKGROUND: It has been established that skeletal growth is stunted in lead-exposed children.
Because chondrogenesis is a seminal step during skeletal development, elucidating the impact of Pb
on this process is the ﬁrst step toward understanding the mechanism of Pb toxicity in the skeleton.
OBJECTIVES: The aim of this study was to test the hypothesis that Pb alters chondrogenic commit-
ment of mesenchymal cells and to assess the effects of Pb on various signaling pathways.
METHODS: We assessed the inﬂuence of Pb on chondrogenesis in murine limb bud mesenchymal
cells (MSCs) using nodule formation assays and gene analyses. The effects of Pb on transforming
growth factor-β (TGF-β) and bone morphogenetic protein (BMP) signaling was studied using
luciferase-based reporters and Western analyses, and luciferase-based assays were used to study cyclic
adenosine monophosphate response element binding protein (CREB), β-catenin, AP-1, and nuclear
factor-kappa B (NF-κB) signaling. We also used an ectopic bone formation assay to determine how
Pb affects chondrogenesis in vivo.
RESULTS: Pb-exposed MSCs showed enhanced basal and TGF-β/BMP induction of chondrogenesis,
evidenced by enhanced nodule formation and up-regulation of Sox-9, type 2 collagen, and aggrecan,
all key markers of chondrogenesis. We observed enhanced chondrogenesis during ectopic bone
formation in mice preexposed to Pb via drinking water. In MSCs, Pb enhanced TGF-β but inhib-
ited BMP-2 signaling, as measured by luciferase reporter assays and Western analyses of Smad
phosphorylation. Although Pb had no effect on basal CREB or Wnt/β-catenin pathway activity, it
induced NFκB signaling and inhibited AP-1 signaling.
CONCLUSIONS: The in vitro and in vivo induction of chondrogenesis by Pb likely involves modula-
tion and integration of multiple signaling pathways including TGF-β, BMP, AP-1, and NFκB.
KEY WORDS: BMP signaling, chondrogenesis, lead, mesenchymal stem cells, TGF-β signaling.
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slices of catﬁsh cerebellum (Leal et al. 2006)
and rat hippocampus (Cordova et al. 2004),
and activation of ERK1/2 in the GT1-7 neu-
ronal cell line (Zhang et al. 2003) and in lung
CL3 cells (Lin et al. 2003). In immortalized
human fetal astrocytes, Pb induces vascular
endothelial growth factor expression through
activation of PKC/AP-1 signaling (Hossain
et al. 2000).
In vitro studies have shown important Pb
effects on chondrocyte phenotype, including
decreased proliferation, inhibition of type X
collagen expression and synthesis, and an
increase in proteoglycan synthesis (Hicks et al.
1996). In addition, Pb has important in vivo
effects on endochondral bone formation, as
Pb-exposed mice and rats have altered growth
plate morphology and decreased longitudinal
growth (Gonzalez-Riola et al. 1997; Hamilton
and O’Flaherty 1994). Correlating with this,
we have found that Pb affects develop-
mental/healing processes in the skeleton. This
is based on our recent ﬁnding that Pb exposure
inhibits fracture healing in mice (Carmouche
et al. 2005). We have also shown that Pb alters
TGF-β and parathyroid hormone–related pep-
tide signaling in chondrocytes undergoing
hypertrophic differentiation in culture, an
important cellular process that occurs during
skeletal development and growth, as well as
during healing (Zuscik et al. 2002b). Thus,
further elucidation of the molecular mecha-
nism of Pb toxicity during skeletal healing
and chondrogenic differentiation in develop-
mental situations is of paramount impor-
tance. For the experiments in this study, we
used primary limb bud mesenchymal stem
cells obtained from stage E11.5 mice, as well
as an ectopic bone formation model in vivo in
mice, to demonstrate a robust chondrogenic
stimulation by Pb. Signaling experiments in
the cell model indicate that Pb enhances
TGF-β signaling and impaires BMP signal-
ing. Interestingly, although Pb increased
chondrogenesis on its own in micromass cul-
tures of the limb bud cells, it enhanced the
chondrogenic effects of both TGF-β and
BMP-2. When considering this ﬁnding from
the perspective of the signaling data, it is clear
that Pb mediates its effects on chondrogenesis
in a Smad-independent manner.
Methods
Mesenchymal stem cell isolation and culture.
We prepared stage E11.5 mouse limb bud
mesenchymal stem cells (MSCs) by enzymatic
digestion of limb bud tissue as previously
described (Zhang et al. 2004). Brieﬂy, CD-1
female mice were euthanized via cervical dis-
location 11.5 days after induction of preg-
nancy, and embryos were removed and placed
in Puck’s saline containing glucose. With the
aid of a dissecting microscope, forelimbs were
removed with forceps and placed in a Puck’s
saline solution containing 10% chick serum
(Gibco Invitrogen, Carlsbad, CA). Following
harvest, limb buds were digested for 45 min in
the identical solution supplemented with 0.1%
dispase (Sigma, St. Louis, MO). After the
digestion, cells were washed several times in
serum-free Dulbecco’s modiﬁed Eagle medium
(DMEM) and counted. Freshly isolated cells
were plated in micromass (105 cells/10 µL)
with a DME/F12 mixture (40%/60%) sup-
plemented with 10% fetal bovine serum
(FBS; Gibco) as previously described (Zhang
et al. 2004). One micromass was seeded per
well in 24-well plates. After attachment of the
cells, wells were flooded with 0.5 mL of the
same culture medium mix and experiments
commenced.
Cartilage nodule formation assay in micro-
mass cultures of MSCs. Three days after seeding
of micromass cultures and treatment with vari-
ous Pb concentrations and/or factors of interest,
wells were washed once with phosphate-
buffered saline (PBS; pH 7.4) and then ﬁxed
for 20 min with 1 mL 10% neutral buffered
formalin (VWR, Buffalo Grove, IL). The cul-
tures were then washed three times with sterile
distilled, deionized water, with the last wash
being left on the cells for 15 min. Subsequently,
0.5 mL 3% alcian blue (Sigma) in glacial acetic
acid was added to each well for 24 hr at room
temperature. After two washes with 70%
ethanol and three washes with sterile distilled,
deionized H2O, photomicrographs of the
stained cultures were obtained. Quantiﬁcation
of alcian blue staining was performed using
NIH Image (National Institutes of Health,
Bethesda, MD). The threshold was standard-
ized to detect nodule area, and the area of the
staining was converted from pixels to square
millimeters. The area and intensity values were
recorded and used to determine staining
intensity.
RNA isolation and real time reverse tran-
scription-polymerase chain reaction (RT-PCR).
Cultures were harvested at various time points,
and mRNA was prepared using Trizol reagent
(Invitrogen, Carlsbad, CA) as directed by the
manufacturer. cDNA was generated using the
Advantage RT-for-PCR kit (Clontech,
Mountain View, CA), and real-time quantita-
tive RT-PCR was performed as described pre-
viously (Zuscik et al. 2002a, 2004). Briefly,
reactions were carried out using the Rotor
Gene Real-Time DNA Ampliﬁcation System
(Corbett Research, Sydney, Australia) accord-
ing to the manufacturers instructions. cDNA
samples were treated with RNase A (Roche
Applied Science, Indianapolis, IN), and 50-ng
aliquots were combined in a 20-µL ﬁnal vol-
ume with 0.5 mM primers and the SYBR
Green PCR Master Mix (Applied Biosystems,
Foster City, CA). The PCR protocol began
with 94°C denaturation (5 min) and then 
followed by 35 cycles of the following: 94°C
denaturation (20 sec); 50–60°C annealing
(20 sec; primer dependent); and 68°C exten-
sion (30 sec). Dilutions of the cDNA pool were
used for each primer set to generate a standard
curve, which was utilized by RotorGene soft-
ware (Corbett Life Science, Sydney, Australia)
to perform quantitative analyses. Data were
normalized to the β-actin expression level for
each sample. All samples were run in triplicate
and repeated four times (n = 4).
In vivo chondrogenesis/bone formation
assay. Use of mice in this experiment was
reviewed and approved by the University of
Rochester Institutional Animal Care and Use
Committee (IACUC). Mice were treated
humanely with regard for alleviation of suffer-
ing. At 10 weeks of age, female C57/B6 mice
were divided into three groups of 35 mice.
Groups were exposed to 0, 55, or 230 ppm Pb
(in the form of Pb acetate) in drinking water for
6 weeks before initiation of the ectopic bone
formation experiment. Our group previously
used an atomic absorption method to establish
that these doses of Pb exposure correspond to
environmentally relevant whole-blood Pb con-
centrations of 15 and 40 µg/dL for 55 and
230 ppm, respectively (Carmouche et al. 2005).
Ectopic bone formation was induced in
mice by the intramuscular implantation of a
gel foam substrate impregnated with cells
expressing BMP-2. Specifically, C9 cells
derived from murine C3H10T1/2 mesen-
chymal stem cells, which express BMP-2 under
control of a doxycycline-repressible promoter,
were cultured in DMEM with 10% FBS,
1% penicillin/streptomycin, 2 mM L-gluta-
mine, and 1 µg/mL doxycycline to repress
BMP-2 expression (gift from D. Gazit,
Hebrew University-Hadassah Medical and
Gene Therapy Center, Jerusalem, Israel). Nine
days before implantation, doxycycline was
removed from the medium to allow BMP-2
expression, which was confirmed using an
ELISA kit (R&D Systems, Minneapolis, MN).
As a negative control, wild type C3H10T1/2
cells were cultured in basal medium Eagle
(BME) with 10% FBS, 1% penicillin/strepto-
mycin, and 2 mM L-glutamine. Cells from
both lines were washed, trypsinized, counted,
and resuspended in medium at a concentra-
tion of 106 cells/100 µL. Surgifoam (type I
collagen sponges; Pharmacia, Piscataway, NJ)
was cut into 2 mm × 2 mm × 2 mm segments
and soaked in medium, then excess ﬂuid was
removed. Aliquots (100 µL) of the cell sus-
pension were micropipetted into each section
of gel foam and incubated for 2 hr to allow
cells to adhere.
Using an IACUC-approved surgical proto-
col, we placed C9 cell-impregnated gel foam
segments into a muscle pouch in the right
quadricep of each mouse; C3H10T1/2-impreg-
nated gel foam was placed in the contralateral
Pb induces chondrogenesis
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were allowed to develop for 3–28 days after
implantation. At each time point, tissue was
harvested, fixed in 10% formalin for 3 days,
embedded in parafﬁn, and cut into 5-µm sec-
tions. Three sections 30 µm apart were stained
with alcian blue and counterstained with
alcian blue/hematoxylin. Three representative
sections from each sample at day 5 and day 7
were analyzed using Osteometrics software
(Osteometrics Inc., Decatur, GA). Cartilage
cross-sectional area was measured for each slide
and included in statistical analysis (for five
nodules, n = 15 for statistical purposes).
Luciferase reporter assays. We performed
experiments to assess signaling on various path-
ways including TGF-β/Smad, BMP/Smad,
NF-κB, TOPFLASH (basal c-fos-luciferase),
AP1, and cyclic adenosine monophosphate
response element binding protein (CREB).
Reporter and control plasmids for each of these
pathways was transfected into MSCs plated as
a monolayer, and then cells were trypsinized
and replated as a micromass as described
above. Thus, MSCs were initially plated in
monolayer in 6-cm dishes at a density of
8 × 105 cells per dish. Twelve hours after plat-
ing, cells were transfected with either
P3TP-luciferase (Luc), 12 × Smad binding ele-
ment (SBE)-Luc, NF-kB-Luc, TOPFLASH,
AP1-Luc, or cAMP-responsive element
(CRE)-Luc. These transfections were per-
formed using Superfect (Qiagen, Valencia,
CA) according to the manufacturers instruc-
tions. The SV40 Renilla-Luc plasmid was co-
transfected to facilitate determination of
transfection efﬁciency on a well-by-well basis,
as previously described (Ferguson et al.
2000). The DNA:transfection-reagent ratio
used for all experiments was 1:3 (weight/vol-
ume) with the following amounts of DNA in
0.6 mL medium: Reporter of interest, 2 µg;
SV40 Renilla-luc, 10 ng. Eight hours after
transfection, cells were trypsinized, counted,
and re-plated in micromass culture as described
above. Within 12 hr of replating, cells were
exposed to various treatments; 48 hr later, cells
were lysed and extracts were prepared using the
Dual Luciferase Assay System (Promega,
Madison, WI), as directed by the manufac-
turer. An Optocomp luminometer (MGM
Instruments, Sparks, NV) was used to measure
luminescence in the extracts.
Western blotting. After rinsing the cell layer
with PBS, protein was extracted from micro-
mass cultures using Golden lysis buffer contain-
ing protease inhibitor cocktail tablets (Roche
Applied Science) as previously described
(Samuels et al. 1993). The lysate was cen-
trifuged at 12,000 × g and the insoluble mater-
ial was removed. The protein concentration of
the soluble material was determined via the
Bradford Kit (Invitrogen). Aliquots of protein
extract (25 µg) were separated by SDS-PAGE
(10% polyacrylamide) and then transferred to
a polyvinylidene ﬂuoride membrane (Schleider
and Schuell, Dassel, Germany). The blots were
probed overnight at 4°C with the following
rabbit anti-mouse polyclonal antibodies:
phospho-Smad3 (Cell Signaling Technology,
Danvers, MA), phospho-Smad1/5/8 (Cell
Signaling Technology), or mouse anti-
β-actin monoclonal antibody (Santa Cruz
Biotechnology, Santa Cruz, CA). All primary
antibodies were applied at a 1:1,000 dilution.
Blots were further incubated for 1 hr at 20°C
in the presence of horseradish peroxidase–
conjugated secondary antibodies against rab-
bit or mouse (both from BioRad, Hercules,
CA) at a dilution of 1:3,000. The immune
complexes were detected using ECL-Femto
(Pierce, Rockford, IL) and visualized via
exposure of X-OMAT AR film (Kodak,
Rochester, NY).
Results
Pb stimulates chondrogenesis and enhances the
chondrogenic effect of BMP-2 and TGF-β.
MSCs were placed in micromass culture and
were treated with Pb in the presence and
absence of BMP-2 (50 ng/mL) and TGF-β
(5 ng/mL). After 3 days in culture, treatment
with Pb resulted in a stimulation of chondro-
genesis as measured by the presence of alcian
blue nodules (Figure 1A). The effect was dose
dependent with quantiﬁcation of nodule for-
mation showing a 2-fold increase present at
1 µM Pb and nearly a 3-fold increase noted at
10 µM Pb (Figure 1B). As anticipated, treat-
ment of the cultures with BMP-2 or TGF-β led
to an induction of chondrogenesis. Although
the effect of BMP-2 was slightly greater
(3.2-fold) than that of TGF-β (1.7-fold), the
induction of chondrogenesis by both growth
factors was enhanced by Pb (Figure 1B). In the
presence of 10 µM Pb, BMP-2 induced
chondrogenesis 5-fold and TGF-β induced a
3-fold increase (Figure 1B). Thus, Pb induces
chondrogenesis and enhances the effects of
both BMP-2 and TGF-β on this process.
Pb induces Sox9, col2, and aggrecan
expression and influences regulation of these
genes by BMP-2 and TGF-β. To assess chon-
drogenesis in MSC cultures on the molecular
level, the mRNA expression of Sox9, col2, and
aggrecan were determined via real time
RT-PCR. Consistent with the alcian blue stain-
ing shown in Figure 1, Pb dose-dependently
enhanced the expression of these genes, with
10-µM Pb inducing a 2-fold increase in Sox9, a
5-fold increase in col2, and a 2.5-fold increase
in aggrecan compared with untreated cultures
(Figure 2). Also consistent with the alcian blue
results, Pb enhanced both BMP-2 and TGF-β
regulation of these genes. Speciﬁcally, BMP-2
induction of Sox9 and aggrecan was enhanced
2- to 3-fold by 1 and 10 µM Pb (Figure 2A,C).
Furthermore, in the presence of both BMP-2
and Pb, col2 expression was increased to levels
above that seen with either BMP-2 or Pb alone
(Figure 2B). Comparatively, treatment with a
combination of TGF-β and Pb caused an
induction of Sox9, col2, and aggrecan that was
generally less than the respective effect of Pb
alone (Figure 2A–2C). These results further
support the hypothesis that Pb inﬂuences chon-
drogenesis directly and inﬂuences chondrogenic
regulation induced by BMP-2 and TGF β.
Zuscik et al.
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Figure 1. Effects of Pb exposure on chondrogenesis and the chondrogenic impact of BMP-2 and TGF-β in MSCs treated with 0, 1, or 10 mM lead acetate either
alone or in the presence of 50 ng/mL BMP-2 or 5 ng/mL TGF-β( see “Materials and Methods” for details). (A) Representative photomicrographs of stained cultures.
(B) Quantiﬁcation of the nodule area (mean ± SE; relative to control). Signiﬁcance was assessed via ANOVA (n = 3; p < 0.05). 
*Signiﬁcantly different from the untreated control. **Signiﬁcantly different from either the BMP-2-treated control or the TGF-β-treated control.
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3 mmPb stimulates BMP-2–induced chondro-
genesis in vivo. To complement the in vitro
ﬁndings discussed above, chondrogenesis was
examined in the context of an in vivo murine
model of ectopic bone formation in which we
used control C3H10T1/2 cells or C9 cells. A
total of 1 × 106 cells were loaded into 2 mm ×
2 mm × 2 mm type I collagen sponges and
then implanted into the medial thigh muscula-
ture of C57/B6 mice pretreated with normal
drinking water or water containing Pb (55 or
230 ppm) for 6 weeks. In control C3H10T1/2
cell implanted limbs, we observed prolifera-
tion of host mesenchymal cells at the periph-
ery of the implant, but no cartilage tissue
formed (Figure 3A). This is consistent with
the requirement that BMP-2 is required to
initiate the chondrogenic commitment of
implanted and/or host cells. It should be
noted that control cells did not support a
chondrogenic response in Pb-exposed mice
(data not shown). In limbs implanted with
BMP-2–expressing C9 cells, the mesenchymal
cell proliferation was associated with evidence
of chondrogenesis beginning at 5 days
(Figure 3A). Administration of Pb in the
drinking water was associated with a dose-
dependent increase in chondrogenesis in 5-day
and 7-day tissue samples from C9-injected
mice. Quantiﬁcation of the cartilage content
via histomorphometry at these time points
conﬁrms the dose dependency of the Pb effect,
with the 230-ppm Pb level showing the most
robust increase in cartilage area and the per-
cent of the mesenchyme that consisted of car-
tilage (Figure 3B). These findings are
consistent with the in vitro data presented in
Figure 1 by demonstrating that Pb enhances
BMP-2 induction of chondrogenic responses.
Pb increases TGF-β–mediated stimulation
of p3TP-Luc and increases Smad3 phosphory-
lation. MSCs were transfected with the
TGF-β/Smad3 responsive reporter p3TP-Luc
and treated with Pb in the presence and
absence of TGF-β. Alone, Pb did not alter
reporter activity, whereas TGF-β (5 ng/mL)
induced a 2.5-fold stimulation (Figure 4A).
However, Pb enhanced the effect of TGF-β
on the p3TP-Luc promoter, with a maximal
5-fold effect occurring at the 10-µM Pb con-
centration (Figure 4A). Consistent with these
ﬁndings, Western blot analysis showed that Pb
did not alter levels of phospho-Smad3 alone,
but resulted in increased Smad3 phosphoryla-
tion in cells stimulated with TGF-β for 1 hr
(Figure 4B). These results demonstrate that Pb
inﬂuences TGF-β signaling and targets Smad3
signaling events.
Pb inhibits BMP-2-induction of 12 ×
SBE-Luc and phosphorylation of Smad1/5/8.
MSCs were transfected with the BMP-
responsive reporter 12 × SBE-Luc and treated
with Pb in the presence and absence of
BMP-2 (100 ng/mL). Pb itself did not alter
reporter activity, but BMP-2 stimulated a
2.4-fold induction. Interestingly, Pb induced
a dose-dependent inhibition of BMP-2–
induced signaling on the 12 × SBE-Luc pro-
moter, with a maximal 65% inhibition
occurring at a concentration of 10 µM Pb
(Figure 5A). Consistent with this ﬁnding, Pb
did not alter levels of phospho-Smad1/5/8
alone, although it had a marked dose-depen-
dent inhibitory effect on BMP-2 stimulation
of Smad1/5/8 phosphorylation (Figure 5B).
Effects were present by 30 min after exposure
and were sustained at 1 hr. These results
demonstrate that Pb strongly inhibits BMP-2
signaling (which is opposite the effect of Pb
on TGF-β signaling) and suggest another
mechanism by which Pb can affect the
process of chondrogenesis.
Pb induces chondrogenesis
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Figure 2. Effects of Pb exposure on Sox9 (A), col2 (B), and aggrecan (C) mRNA expression (mean ± SE; relative to control) in MSCs treated with 0, 1, or 10 µM Pb
acetate either alone or in the presence of 50 ng/mL BMP-2 or 5 ng/mL TGF-β. Signiﬁcance was assessed via ANOVA (n =3 ;p < 0.05). 
*Signiﬁcantly different from the untreated control. **Signiﬁcantly different from either the BMP-2–treated control or the TGF-β–treated control.
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Figure 3. Effects of Pb exposure (0, 55, or 350 ppm) on chondrogenesis in an in vivo model [C3H10T1/2 cells or
C9 cells (BMP-2 expressing C3H10T1/2 cells)] of ectopic bone formation (see “Materials and Methods” for
details). (A) Representative photomicrographs of tissues stained with Alcian blue and hematoxylin. (B) The
cartilage area and the percentage of mesenchyme consisting of cartilage quantiﬁed by histomorphometry
using Osteometrics software (mean ± SE). Signiﬁcance was assessed using ANOVA (n = 15; p < 0.05).
*Signiﬁcantly different from the untreated control at the same time point.
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230 ppmPb has differential effects on AP-1, CRE,
NFκB, and Wnt/β-catenin signaling. Because
Pb has no effect on basal TGF-β–Smad and
BMP-Smad signaling, and has opposite effects
on these signaling pathways in the presence of
their respective growth factors, it is unlikely
that the induction of chondrogenesis by Pb is
related to direct regulation of Smad signaling.
To determine the possible involvement of
other pathways known to be important in the
process of chondrogenesis, MSCs were trans-
fected with AP1-Luc, NFκB-Luc, CRE-Luc,
and TOPFLASH reporters, each containing
multiple repeats of the respective consensus
binding sites. Although there was no effect of
Pb on CRE or TOPFLASH activity (Figure
6A,B), Pb caused a dose-dependent decrease in
basal AP1 activity that was maximal (40%) in
cultures treated with 10 µM Pb (Figure 6C).
Finally, Pb induced a dose-dependent but
not significant increase in NFκB activity
(Figure 6D). These results suggest that inﬂu-
ences of Pb on chondrogenesis may also be
partially dependent on a direct alteration of
AP1 signaling.
Discussion
There is growing awareness of the pleiotropic
effects of Pb, with targets of toxicity including
multiple tissues that include the skeleton. In
fact, at concentrations considered subtoxic, Pb
is known to affect skeletal growth. The two
most recent National Health and Nutrition
Examination Surveys (NHANES II and
NHANES III) have demonstrated that Pb
exposure reduces skeletal growth independent
of factors such as nutritional status, social/
economic class, and co-morbid diseases (Ballew
et al. 1999). Moreover, signiﬁcant developmen-
tal effects are apparent at blood concentrations
as low as 4 µg/dl (Ballew et al. 1999). Thus,
skeletal tissues, and particularly the growth
plate, are among the most sensitive tissue tar-
gets of Pb. Representing a first step toward
understanding the mechanism underlying the
inﬂuence of Pb on the skeleton, ﬁndings pre-
sented in this article demonstrate that Pb tar-
gets mesenchymal stem cells and affects the
determination of cell fate. Speciﬁcally, embry-
onic limb bud cells exposed to Pb display a
severalfold increase in chondrogenenic commit-
ment. Moreover, Pb induces the chondrogenic
effects of both BMP-2 and TGF-β. Because
embryonic limb bud stem cells also have the
potential to differentiate into other mesen-
chymal tissues, Pb possibly also inﬂuences the
cell fate on other cell differentiation pathways.
Pb has broad and complex effects on mul-
tiple intracellular signaling pathways. As men-
tioned above, Pb has been shown in various
tissues to a) block calcium signaling and
inhibit Ca2+/phospholipid-dependent PKC
signaling (Pokorski et al. 1999; Vazquez and
Pena 2004); b) induce ERK1/2 and p38
(MAPK) phosphorylation and activation (Lin
et al. 2003; Zhang et al. 2003); and c) activate
AP-1 signaling (Hossain et al. 2000). We have
found that Pb affects neither basal BMP-2 nor
TGF-β signaling; thus it is unlikely that the
effect of Pb on chondrogenesis is related to a
direct alteration of these signaling pathways.
Moreover, although Pb enhanced the effect of
BMP-2 on chondrogenesis, it acted as an
inhibitor of Smad1/5/8 signaling. Further
experiments demonstrated that Pb also regu-
lates other signaling pathways, including AP-1
and possibly NFκB. Thus, it appears that the
effects of induction of chondrogenesis and
enhancement of TGF-β and BMP-2 on
chondrogenesis are secondary to stimulation
of other interacting signaling pathways.
Previous work has established that Pb regu-
lates BMP and TGF-β signaling pathways.
Oral administration of Pb chloride has been
shown to cause a reduction in the expression of
TGF-β in intestinal tissues in diabetes-prone
NOD mice (Goebel et al. 1999). In an earlier
study using chicken growth plate chondrocyte
cultures (Zuscik et al. 2002b), we found that
both Pb and TGF-β independently inhibit
expression of the maturational marker colX,
Interestingly, this study also showed that inhibi-
tion of colX by TGF-β was completely reversed
by Pb. Furthermore, although neither Pb nor
TGF-β alone affected the expression of BMP-6,
in combination they induced its expression
3-fold (Zuscik et al. 2002b). Although these
previous studies did not fully examine regula-
tion of downstream signaling events, they did
demonstrate a regulation of TGF-β signaling.
When considered along with the current ﬁnd-
ings, it seems clear that the inﬂuence of Pb on
chondrogenesis/chondrocyte differentiation is
at least partially dependent upon the presence
Zuscik et al.
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Figure 5. Effects of Pb on BMP-2–induced signaling (A) and phosphorylation of Smad1/5/8 (B) in MSCs.
(A)1 2   × SBE-Luc signaling (mean ± SE; relative to control) in MSCs plated in a monolayer and co-trans-
fected with 12 × SBE-Luc and SV40 Renilla (efﬁciency control); after 8 hr, cells were trypsinized, counted,
and replated in micromass culture. Sixteen hours after seeding the micromasses, cells were treated with
0, 1, or 10 µM Pb acetate alone or in the presence of 50 ng/mL BMP-2; 48 hr later, the cell layer was solubi-
lized with lysis buffer and sample luminescence was measured. Signiﬁcance was assessed using ANOVA
(n = 3; p < 0.05). (B) Representative Western blot of MSCs seeded into micromass culture and treated with
0, 1, or 10 µM Pb acetate 24 hr later. After a 24-hr preexposure period, cultures were treated either with or
without 50 ng/mL BMP-2. After 30 min, total cellular proteins were harvested and Western blot analysis
was performed to detect phospho-Smad1/5/8 and β-actin (load control). Blots are from a series of three
separate experiments.
*Signiﬁcantly different from the untreated control. **Signiﬁcantly different from the TGF-β-treated control.
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Figure 4. Effects of Pb on TGF-β–induced signaling in MSCs. (A) TGF-β–mediated stimulation of p3TP-Luc
(mean ± SE; relative to control) in MSCs plated in a monolayer and co-transfected with P3TP-Luc and SV40
Renilla (efﬁciency control). After 8 hr, cells were trypsinized, counted, and replated in micromass culture;
16 hr after seeding the micromasses, cells were treated with 0, 1, or 10 µM Pb acetate alone or in the pres-
ence of 5 ng/mL TGF-β. Forty-eight hours later, the cell layer was solubilized with lysis buffer and sample
luminescence was measured; signiﬁcance was assessed using ANOVA (n = 3; p < 0.05). (B) Representative
Western blots of MSCs seeded into micromass culture and treated with 0, 1, or 10 µM Pb acetate 24 hr
later. After a 24 hr preexposure period, cultures were treated either with or without 5 ng/mL TGF-β. After 30
min, total cellular proteins were harvested and Western blot analysis was performed to detect phospho-
Smad3, Smad3, and β-actin (load control). Blots are from a series of three separate experiments. 
*Signiﬁcantly different from the untreated control. **Signiﬁcantly different from the TGF-β-treated control.
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Pb (μM)of TGF-β and activation of its Smad signaling
pathway. Overall, our ﬁndings suggest that Pb
exposure renders mesenchymal precursor cells
more sensitive to TGF-β by increasing Smad3
phosphorylation and signaling. To our knowl-
edge, this is the ﬁrst demonstration of regula-
tion of Smad phosphorylation by Pb in any cell
system.
In the present study, we found that BMP
signaling is also regulated by Pb. BMP receptor
signaling occurs in a manner analagous to the
TGF-β pathway, with Smad1/5/8 binding to
the type I BMP receptor, followed by phospho-
rylation of these factors upon ligand activation
(Miyazono et al. 2005). Using a polyclonal anti-
body that recognizes all three BMP receptor–
associated Smads, we found that the basal
phosphorylation state was not altered by Pb
alone, but the induction of phosphorylation of
Smad1/5/8 was markedly inhibited by Pb.
Similarly, although Pb did not alter basal acti-
vation of the BMP-Smad responsive reporter
12 × SBE, Pb signiﬁcantly reduced activation
of this reporter by BMP-2. Thus, similar to
TGF-β signaling, Pb regulates BMP signaling
only during activation of the pathway by lig-
and. Interestingly, the effects are opposite, with
Pb inhibiting BMP-Smad phosphorylation
and stimulating TGF-β-Smad phosphoryla-
tion. Overall, the potent inhibition of BMP-2–
induced Smad1/5/8 signaling by Pb represents
the most robust signaling effect identiﬁed to
date in a skeletal cell type with regard to a can-
didate mechanism of Pb toxicity.
The complex regulation of the Smad sig-
naling molecules makes it unlikely that the
induction of chondrogenesis by Pb is cause by
direct alteration of these pathways. Although
BMP and TGF-β signaling pathways have
antagonistic effects on some cells, including
growth plate chondrocytes where TGF-β
inhibits and BMP-2 stimulates maturation,
both signals enhance chondrogenesis in mes-
enchymal stem cell populations (Hoffmann
and Gross 2001). An earlier study has shown
that BMP-4 stimulates chondrogenesis in
C3H10T1/2 and MC615 chondroprogenitor
cells through activation of the BMP-receptor–
associated Smads (Hatakeyama et al. 2003).
TGF-β signaling through Smad2 and Smad3
is associated with enhanced chondrogenesis in
murine mesenchymal stem cells (Yu and Xing
2006). Additionally, the action of these fac-
tors is dependent on complex signaling,
because it is clear that TGF-β and BMP sig-
nals act in combination with other signaling
pathways. In ATDC5 cells, stimulation of
chondrogenesis by TGF-β is mediated by
activation of Smad pathways and the p38 and
Erk1/2 MAP kinase pathways simultaneously
(Watanabe et al. 2001). Furthermore, whereas
Wnt/β-catenin signaling in vivo appears to
stimulate osteogenesis over chondrogenesis
(Day et al. 2005), in human mesenchymal
stem cell cultures TGF-β acts synergistically
with Wnt/β-catenin signaling to induce chon-
drogenesis (Zhou et al. 2004). Similarly, BMPs
have been shown to act synergistically with
Wnt/β-catenin signaling to induce chondroge-
nesis in C3H10T1/2 cells (Fischer et al. 2002).
Overall, it is clear that BMP and TGF-β Smad
signaling is critical for induction of chondroge-
nesis; however, these pathways are only a part
of multiple signaling events that contribute to
the regulation of chondrogenic commitment.
To extend these signaling results, we also
examined the effect of Pb on other signaling
pathways. Although no effects were observed
on CRE and TOPFLASH activation using the
respective luciferase-based reporters, the experi-
ments showed that Pb inhibited basal AP-1-
Luc reporter activity. AP-1 activation has been
shown to inhibit chondrogenesis, so it is possi-
ble that the inhibition of AP-1 could be
involved in the induction of chondrogenesis by
Pb (Hwang et al. 2005; Tufan et al. 2002).
The inhibition of AP-1 signaling in mesenchy-
mal stem cells is in contrast to the ﬁndings in
other cells where Pb induces AP-1 signaling
activity. In a previous study (Zuscik et al.
2002b), we showed that Pb increased AP-1
and NFκB signaling in chick embryonic chon-
drocytes in culture. Furthermore, in vitro Pb
exposure in rats results in activation of AP-1
and NFκB levels in multiple regions of the
brain and in astrocytes in culture (Ramesh
et al. 2001). In vivo Pb exposure results in
increased NFκB signaling in renal tubular cells
and results in nephritis in rats (Rodriguez-
Iturbe et al. 2005). Similarly we found that Pb
induces NFκB signaling in MSCs as measured
by induction of NFκB-Luc reporter. However,
because signaling on the NFκB pathway has
been shown to destabilize Sox9 mRNA and
inhibit chondrogenesis (Sitcheran et al. 2003),
it is unlikely that Pb-induction of NFκB sig-
naling seen in MSCs is directly causing an
enhanced chondrogenic response.
The induction of chondrogenesis by Pb in
the current study is consistent with findings
observed in an in vivo murine model of fracture
healing (Carmouche et al. 2005). Mice with Pb
levels similar to those found in humans with Pb
intoxication had delayed healing of stabilized
femur fractures. The effect was dose dependent,
and cartilage was observed to be a major target.
Pb-exposed mice had increased cartilage vol-
umes, delayed chondrocyte maturation, persis-
tence of cartilage, and reduced bone formation
(Carmouche et al. 2005). Overall, when con-
sidered along with the results of Carmouche
et al. (2005), our ﬁndings in the present study
further support the hypothesis that Pb is an
inducer of chondrogenesis.
In conclusion, the present study estab-
lishes that in addition to affecting chondrocyte
Pb induces chondrogenesis
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Figure 6. Effect of Pb on MSCs transfected with CRE-Luc (A), TOPFLASH (B), AP1-Luc (C), or NFκB-Luc (D).
All cultures were co-transfected with SV40 Renilla to control for transfection efﬁciency. After 8 hr, cells
were trypsinized, counted, and replated in micromass culture; cells were treated with 0, 1, or 10 µM Pb
acetate 16 hr later. After 48 hr, the cell layer was solubilized with lysis buffer and sample luminescence
was measured to determine basal signaling activity on each pathway of interest. Values are mean ± SE
normalized to Renilla-Luc. Signiﬁcance was assessed using ANOVA (n = 3; p < 0.05).
*Signiﬁcantly different from the untreated control.
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D Cmaturation, Pb accelerates the differentiation
of mesenchymal precursors into chondrocytes.
Although Pb alters BMP and TGF-β signaling,
the mechanism through which Pb regulates
mesenchymal cell fate determination is com-
plex and likely involves modulation and inte-
gration of multiple signaling pathways.
Increased understanding of the mechanisms
through which Pb regulates stem cell fate and
subsequently affects tissue repair is critical,
given the sensitivity of these tissues and the
ubiquitous presence of Pb in our society and in
other industrialized and developing nations.
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